Skip to search formSkip to main content

Cyclin-Dependent Kinase Inhibitor p57

Known as: Cyclin Dependent Kinase Inhibitor 1C, p57 KIP2 Protein, Cyclin-Dependent Kinase Inhibitor p57 [Chemical/Ingredient] 
A potent inhibitor of CYCLIN-DEPENDENT KINASES in G1 PHASE and S PHASE. In humans, aberrant expression of p57 is associated with various NEOPLASMS as… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
BACKGROUND Distinguishing hydatidiform moles (HMs) from nonmolar specimens and the subclassification of HM are important because… Expand
  • figure 1
  • table 1
  • figure 3
Is this relevant?
2018
2018
Accurate diagnosis and sub-classification of hydatidiform moles (HM) and distinction from non-molar (NM) gestations is important… Expand
Is this relevant?
2011
2011
Elucidating mechanisms of cell cycle control in normally quiescent human pancreatic β-cells has the potential to impact… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
Androgenetic/biparental mosaicism, in which a subset of cells has complete paternal uniparental disomy, is associated with… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2006
2006
p57kip2, a KIP family cyclin-dependent kinase (Cdk) inhibitor, blocks the cell cycle by acting on multiple cyclin-Cdk complexes… Expand
Is this relevant?
2005
2005
The protein investigated in this thesis is the glucocorticoid receptor (GR), which is a ligand activated transcription factor… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2000
2000
In this study we have examined 32 patients with Beckwith Wiedemann Syndrome (BWS) for mutations affecting the CDKN1C gene… Expand
Is this relevant?